Company Filing History:
Years Active: 1988
Title: The Innovative Contributions of Stephen C. Bearekman
Introduction
Stephen C. Bearekman is a notable inventor based in Richmond, VA. He has made significant contributions to the field of pharmaceuticals, particularly in the area of controlling emesis caused by anticancer drugs. His work has the potential to improve the quality of life for patients undergoing cancer treatment.
Latest Patents
Stephen C. Bearekman holds a patent for a method of controlling emesis caused by anticancer drugs. The patent details a method involving 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl) benzamide-N-oxides, which are designed to mitigate the side effects of chemotherapy. This innovative approach is crucial for enhancing patient comfort during treatment.
Career Highlights
Bearekman is associated with A. H. Robins Company, Incorporated, where he has been able to apply his expertise in pharmaceutical development. His work at this company has allowed him to focus on creating effective solutions for patients facing the challenges of cancer therapies.
Collaborations
Throughout his career, Stephen has collaborated with talented individuals such as Lina C. Teng and Lennox B. Turnbull. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Stephen C. Bearekman's contributions to the field of pharmaceuticals, particularly in controlling emesis for cancer patients, highlight his dedication to improving patient care. His innovative methods and collaborations with other professionals underscore the importance of teamwork in advancing medical science.